Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Cortesi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|May 12, 2023
T<sub>H</sub>17 cell immune adaptationTheodora Agalioti, Filippo Cortesi, Nicola Gagliani
Trends in Immunology|November 10, 2023
Diet and immune response: how today's plate shapes tomorrow's healthFrancesco Siracusa, Joseph Tintelnot, Filippo Cortesi, et al.
Frontiers in Immunology|October 30, 2018
The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in TissuesFilippo Cortesi, Gloria Delfanti, Giulia Casorati, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
Human and Murine T-Helper Cell Recovery from Organs and TissuesFrancesco Siracusa, Annette Lahmann, Anna Vanni, et al.
Frontiers in Immunology|March 1, 2024
Purinergic enzymes on extracellular vesicles: immune modulation on the goRiekje Winzer, Du Hanh Nguyen, Felix Schoppmeier, et al.
Journal of Neuro-Oncology|September 29, 2014
Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastomaRoberta Salaroli, Alice Ronchi, Francesca Romana Buttarelli, et al.
Molecular Cancer Therapeutics|June 18, 2009
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell linesFrancesco Crea, Elisa Giovannetti, Filippo Cortesi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 17, 2019
Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged NanogoldAnna Maria Gasparri, Angelina Sacchi, Veronica Basso, et al.
Molecular Cancer Therapeutics|February 18, 2010
Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinibElisa Giovannetti, Paolo A Zucali, Godefridus J Peters, et al.
Science Immunology|August 19, 2022
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cellsGloria Delfanti, Filippo Cortesi, Alessandra Perini, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|May 12, 2023
T<sub>H</sub>17 cell immune adaptationTheodora Agalioti, Filippo Cortesi, Nicola Gagliani
Trends in Immunology|November 10, 2023
Diet and immune response: how today's plate shapes tomorrow's healthFrancesco Siracusa, Joseph Tintelnot, Filippo Cortesi, et al.
Frontiers in Immunology|October 30, 2018
The Pathophysiological Relevance of the iNKT Cell/Mononuclear Phagocyte Crosstalk in TissuesFilippo Cortesi, Gloria Delfanti, Giulia Casorati, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 30, 2021
Human and Murine T-Helper Cell Recovery from Organs and TissuesFrancesco Siracusa, Annette Lahmann, Anna Vanni, et al.
Frontiers in Immunology|March 1, 2024
Purinergic enzymes on extracellular vesicles: immune modulation on the goRiekje Winzer, Du Hanh Nguyen, Felix Schoppmeier, et al.
Journal of Neuro-Oncology|September 29, 2014
Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastomaRoberta Salaroli, Alice Ronchi, Francesca Romana Buttarelli, et al.
Molecular Cancer Therapeutics|June 18, 2009
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell linesFrancesco Crea, Elisa Giovannetti, Filippo Cortesi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 17, 2019
Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged NanogoldAnna Maria Gasparri, Angelina Sacchi, Veronica Basso, et al.
Molecular Cancer Therapeutics|February 18, 2010
Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinibElisa Giovannetti, Paolo A Zucali, Godefridus J Peters, et al.
Science Immunology|August 19, 2022
TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cellsGloria Delfanti, Filippo Cortesi, Alessandra Perini, et al.
Pageof 2